Amazon (AMZN) approaches final stages of Globalstar (GSAT) acquisition to expand satellite network. Apple’s 20% stake adds complexity to negotiations.
Browsing: Stocks
Bitcoin recovered to $73,400 Monday after a 4% weekend drop. Markets bounced back as oil retreated from $105, while Strategy added 13,927 BTC to holdings.
Kraken refuses extortion demands after criminals obtained internal system videos. Federal investigation underway as 2,000 accounts were potentially viewed.
Novo Nordisk (NVO) gains 2.8% after revealing OpenAI partnership to integrate AI in drug discovery, manufacturing, and operations by 2026.
Gold prices rise 0.7% to $4,773 on US-Iran peace talk signals and dollar weakness. Bullion remains range-bound ahead of key PPI inflation data release.
Lululemon (LULU) stock declined over 3% after Texas AG launched investigation into potential PFAS ‘forever chemicals’ in products and consumer claims.
Amazon (AMZN) expands Autos platform to include Kia, Jeep, Chevrolet, and more across 130+ cities, targeting the $1.3T new car market and advertising revenue.
Conagra (CAG) fell to a 52-week low after CEO Sean Connolly announced his exit. Analysts downgrade targets as dividend sustainability concerns mount.
Nokia (NOK) stock gains 2% as Bank of America upgrades to Buy, raising price target to €10.70 on optical networking and AI data center expansion.
Meta (META) is projected to surpass Google in global digital ad revenue by 2026, reaching $243.46B. AI tools and new ad products driving growth.
Anthropic’s revenue could hit $100B by late 2026 as Claude usage doubles and the AI company gains ground against ChatGPT in the chatbot market.
Broadcom (AVGO) gains as UBS lifts AI revenue target to $145B after Google TPU deal extension through 2031 includes Anthropic compute access starting 2027.
Allogene Therapeutics (ALLO) shares jumped 41% following Phase 2 ALPHA3 data showing 58% MRD clearance with no CAR T-related toxicities in lymphoma patients.
Bitmine (BMNR) controls $10.7B in Ethereum, holding 4.04% of total ETH supply. Stock down 32% YTD despite aggressive accumulation strategy.
Oppenheimer upgrades Blackstone (BX) to Outperform with $154 target after sharp decline. Analyst sees 34% upside amid strong Q4 earnings and insider buying.